PARK7 and Parkinson disease: In a mouse model of PD induced by MPTP, long-term administration of phenylbutyrate has shown to increase brain DJ-1 activity, reduce α-syn aggregation, and prevent motor degeneration and cognitive deficits (Zhou et al., 2011).